FDA NDC Directory · JSON-LD · Markdown

KESIMPTA

NDC 0078-1007 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameofatumumab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA125326
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsOFATUMUMAB (20 mg/.4mL)
Marketing started20091026
Package count2

External sources

Source: openFDA. Public-domain (CC0).